A Study of Autoreactive T Cells in Drug-Induced Autoimmune Skin Disease

药物引起的自身免疫性皮肤病中自身反应性 T 细胞的研究

基本信息

  • 批准号:
    01570570
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

1) In the drug eruptions, which were classified to the subgroup of acute cutaneous GVHD (graft-verusus-host disease) type from the clinicohistopathological findings, we observed the dominant infiltration of CD8+ T cells in the epidermis, depletion/reduction of CD1+ epidermal Langerhans cells and remarkable expression of HLA-DR/ICAM-1 on the kerationcytes. These findings are the same as acute cutaneous GVHD itself appeared after bone marrow transplantation and blood transfusion, indicating that essentially the same pathomechanism is involved in the both conditions, and also that enhancement of T cells with cytotoxic activity and the inflammatory cytokines such as IFNgamma and TNFalpha may play an important role in development of GVHD itself and GVHD-like reaction by drugs.2) In the footpad reactions by local transfer of sulfhydril drug, tiopronin (TP)-sensitized lymph node cells (LC) and spleen cells (SC), IFNgamma and TNFalpha were also required for the full induction of GVHD-like reactions.3) We have already revealed that IFNgamma, which is released from the activated T cells, enhances the expression of bullous pemphigoid (BP) antigen on the cultured keratinocytes by flow cytometory. In this study we revealed the enhanced expression of BP antigen in the messenger RNA levels by slot blot hybridization. These results reconfirmed the possibility that cytokines such as IFNgamma from the activated T cells might be involved in development of autoimmune bullous pemphigoid.
1)在药物喷发中,该药物被分类为临床组织病理学发现的急性皮肤GVHD(移植物 - 宿主疾病)类型的亚组,我们观察到表皮中CD8+ T细胞的显性浸润,CD1+表皮降低/降低CD1+ Ectermeral的降低/还原Langerhans细胞和HLA-DR/ICAM-1在Kerationcytes上的显着表达。这些发现与骨髓移植和输血后出现了急性皮肤GVHD本身,表明两种情况中基本上涉及相同的病理机制,并且还具有细胞毒性活性和炎性细胞因子(如Ifngamma和ifngamma和ifngamma and ifngamma and ifngamma and ifngamma and ifngamp and and the the complocy tnfalpha可能在GVHD本身的发展和药物的GVHD样反应中发挥重要作用。2)在植入反应中,硫化药物的局部转移TIORPRONIN(TP)敏感性淋巴结细胞(LC)和脾细胞(SC)(SC)(SC)通过局部转移。 ,还需要为GVHD样反应的全部诱导,还需要Ifngamma和Tnfalpha。流式细胞图。在这项研究中,我们揭示了通过插槽印杂交在使者RNA水平中BP抗原的表达增强。这些结果重新确认了活化T细胞等细胞因子(例如IFNGAMMA)可能参与自身免疫性大肠杆菌的发展。

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
池沢 善郎: "実験的薬疹" 現代皮膚科学大系、年刊版'88ーB、中山書店, 117-135 (1988)
池泽义郎:“实验性药疹”现代皮肤病学,年度版 88-B,中山书店,117-135 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suguta Y,Nagatani T,Ikezawa Z,Nomura K,Watanabe Y,Uitto J,Nakajima H: "Modification of bullous pemphigoid antigen protein and gene expression by γーinterferon" Journal of Investigative Dermtology. (1991)
Suguta Y、Nagatani T、Ikezawa Z、Nomura K、Watanabe Y、Uitto J、Nakajima H:“γ-干扰素对大疱性类天疱疮抗原蛋白和基因表达的修饰”《皮肤病学研究杂志》(1991 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikezawa Z,Aihara M,and Kitamura K: "Drugーinduced rashes in guinea pigs" Models in Dermatology IV edited by Maibach HI and Lowe NJ,Karger,Basel, 79-95 (1989)
Ikezawa Z、Aihara M 和 Kitamura K:“豚鼠药物引起的皮疹”皮肤病学模型 IV,由 Maibach HI 和 Lowe NJ 编辑,Karger,巴塞尔,79-95 (1989)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Saito S, Miyamoto H, Kim S, Ikezawa Z, Nakajima H: "Immunological study of DDS syndrome" Jpn. Clin. Dermatol.43(13). 1267-1271 (1989)
Saito S、Miyamoto H、Kim S、Ikezawa Z、Nakajima H:“DDS 综合征的免疫学研究”Jpn。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikezawa Z,Kitamura K,Nakajima H: "Gold sodium thiomalate(GTM)induces hypersensitivity to thiomalate,the thiol carrier of GTM" The Journal of Dermatology. 17. 550-554 (1990)
Ikezawa Z、Kitamura K、Nakajima H:“硫代苹果酸金钠 (GTM) 会诱导对硫代苹果酸(GTM 的硫醇载体)过敏”《皮肤病学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IKEZAWA Zenro其他文献

IKEZAWA Zenro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IKEZAWA Zenro', 18)}}的其他基金

Challenge to the developmental study of new biomarker and new treatment in recalcitrant allergic skin disease
难治性过敏性皮肤病新生物标志物和新疗法开发研究面临的挑战
  • 批准号:
    21591471
  • 财政年份:
    2009
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developmental study of new biomarker and new treatment in recalcitrant allergic skin disease
顽固性过敏性皮肤病新生物标志物及新疗法的开发研究
  • 批准号:
    19591320
  • 财政年份:
    2007
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study of pathomechanism of drug/metal allergy by oral administration
口服药物/金属过敏的发病机制研究
  • 批准号:
    04807074
  • 财政年份:
    1992
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了